Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8325 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-01-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was a target trial emulation using the National Health Claims database established by the Korean National Health Insurance Service (K-NHIS). 8,325 patients were included.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognostic Impact of NLR, PLR, and MPV in Patients Undergoing AAA Open Repair

NCT05031195

Abdominal Aortic Aneurysm

COMPLETED

Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms

NCT01683084

Abdominal Aortic Aneurysm

COMPLETED PHASE4

Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair

NCT03347812

Aortic Dissection Aortic Arch Aneurysm Ulcer +1 more

UNKNOWN

Safety and Efficacy of the SETA LATECBA Stent Graft for EVAR in Subjects With AAA

NCT04220177

Abdominal Aortic Aneurysm

UNKNOWN NA

NExT ERA: National Expertise Based Trial of Elective Repair of Abdominal Aortic Aneurysms: A Pilot Study

NCT00358085

Aortic Aneurysm, Abdominal

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Among these patients, any patients who were prescribed SAPT or DAPT at the date of discharge from the index hospitalization for standard EVAR were defined as being in the SAPT group (N=4,162) and the DAPT group (N=4,163), respectively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Aortic Aneurysms (AAA) Endovascular Aneurysm Repair (EVAR)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dual antiplatelet therapy

Patients who were prescribed dual antiplatelet therapy at the date of discharge from the index hospitalization for standard EVAR

No interventions assigned to this group

Single antiplatelet therapy

Patients who were prescribed single antiplatelet therapy at the date of discharge from the index hospitalization for standard EVAR

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who underwent EVAR for AAA and were successfully discharged

Exclusion Criteria

* Patients who had experienced a myocardial infarction
* Patients who had experienced a stroke
* Patients who had experienced percutaneous coronary intervention
* Patients who had history of peripheral disease
* Patients who had major bleeding event within 1 year of admission
* Those prescribed non-vitamin K antagonist oral anticoagulant or warfarin
* Patients who did not prescribe any antiplatelet therapy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No